Tissue factor expression and prognosis in patients with metastatic prostate cancer

Urology

Volumn 62, Issue 6, 2003, Pages 1078-1082

  Akashi, Takuya ^a   Furuya, Yuzo ^a   Ohta, Shoichiro ^a   Fuse, Hideki ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORMADINONE ACETATE; FOSFESTROL; THROMBOPLASTIN;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; EVALUATION; HORMONAL THERAPY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CARCINOMA; PROTEIN EXPRESSION;

EID: 0344234459     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00768-4     Document Type: Article

References (29)

1. Nemerson Y. Tissue factor and hemostasis. Blood. 71:1988;1-8.
2. Edgington T.S., Mackman N., Brand K., et al. Structural biology of expression and function of tissue factor. Thromb Haemost. 66:1991;67-79.
3. Drake T.A., Morrissey J.H., Edgington T.S. Selective cellular expression of tissue factors in human tissues implications for disorders of hemostasis and thrombosis . Am J Pathol. 134:1989;1087-1097.
4. Fleck R.A., Rao L.V., Rapaport S.I., et al. Localization of human tissue factor antigen by immunostaining with monospecific polyclonal antihuman tissue factor antibody. Thromb Res. 59:1990;421-437.
5. Rickles F.R., Edwards R.L. Activation of blood coagulation in cancer Trousseau's syndrome revisited . Blood. 62:1983;14-31.
6. Senger D.R., Galli S.J., Dvorak A.M., et al. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. 219:1983;983-985.
7. Carmeliet P., Mackman N., Moons L., et al. Role of tissue factor in embryonic blood vessel development. Nature. 9:1996;73-75.
8. Hashizume H., Baluk P., Morikawa S., et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol. 156:2000;1363-1380.
9. Gralnick H.R., Abrell E. Studies of the procoagulant and fibrinolytic activity of promyelocytes in acute promyelocytic leukemia. Br J Haematol. 24:1973;89-99.
10. Wada H., Nagano T., Tomeoku M., et al. Coagulant and fibrinolytic activities in the leukemic cells lysates. Thromb Res. 30:1983;315-322.
11. Callander N.S., Varki N., Rao V.M. Immunohistochemical identification of tissue factor in solid tumors. Cancer. 5:1992;1194-1201.
12. Sturm U., Luther T., Albrecht S., et al. Immunohistological detection of tissue factor in normal and abnormal human mammary glands using monoclonal antibodies. Virchows Arch A Pathol Anat Histopathol. 421:1992;79-86.
13. Kakkar A.K., Lemoine N.R., Scully M.F., et al. Tissue factor expression correlates with histological grade in human pancreatic cancer. Br J Surg. 82:1995;1101-1104.
14. Hamada K., Kuratsu J., Saitoh Y., et al. Expression of tissue factor correlates with grade of malignancy in human glioma. Cancer. 77:1996;1877-1883.
15. Higure A., Okamoto K., Hirata K., et al. Macrophages and neutrophils infiltrating into the liver are responsible for tissue factor expression in a rabbit model of acute obstructive cholangitis. Thromb Haemost. 75:1996;791-795.
16. Bromberg M.E., Konigsberg W.H., Madisons J.F., et al. Tissue factor promotes melanoma metastasis by a pathway independent of blood coagulation. Proc Natl Acad Sci USA. 92:1995;8205-8209.
17. Fischer E.G., Ruf W., Mueller B.M. Tissue factor-initiated thrombin generation activates the signaling thrombin receptor on malignant melanoma cells. Cancer Res. 55:1995;1629-1632.
18. Zhang Y., Deng Y., Luther T., et al. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest. 94:1994;1320-1327.
19. Weidner N., Carroll P.R., Flax J., et al. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol. 143:1993;401-409.
20. Catalona W.J., Smith D.S. 5-year tumor recurrence rates after radical retropubic prostatectomy for prostate cancer. J Urol. 152:1994;1837-1842.
21. Lerner S.E., Blute M.L., Bergstralh E.J., et al. Analysis of risk factors for progression in patients with pathologically confined prostate cancers after radical retropubic prostatectomy. J Urol. 156:1996;137-143.
22. Lissbrant I.F., Stattin P., Damber J.E., et al. Vascular density is a predictor of cancer-specific survival in prostatic carcinoma. Prostate. 33:1997;338-345.
23. Catalona W.J., Smith D.S. Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer intermediate-term results . J Urol. 160:1998;2428-2434.
24. Abdulkadir S.A., Carvalhal G.F., Kaleem A., et al. Tissue factor expression and angiogenesis in human prostate carcinoma. Hum Pathol. 31:2000;443-447.
25. Ohta S., Wada H., Nakazaki T., et al. Expression of tissue factor is associated with clinical features and angiogenesis in prostate cancer. Anticancer Res. 22:2002;2991-2996.
26. Nakamura S., Goto A., Takemoto S., et al. Monoclonal antibodies to human tissue factor. (abstract) Thromb Haemost. 65:1991;1216.
27. Gleason D.F. Histologic grading of prostate cancer a perspective . Hum Pathol. 23:1992;273-279.
28. Soloway M.S. The importance of prognostic factors in advanced prostate cancer. Cancer. 66:1990;1017-1021.
29. Contrino J., Hair G., Kreutzer D., et al. In situ detection of tissue factor in vascular endothelial cells correlation with the malignant phenotype of human breast disease . Nat Med. 2:1996;209-214.